The abstract is read at the publisher; the summary is JClub's.
A 96-hour exposure to 1000 uM palmitic acid does not impair insulin signalling in SGBS adipocytes, and their secretome fails to reduce Akt phosphorylation in human myotubes.
- Why it matters: Energy excess from long-chain saturated fatty acids may drive obesity-related metabolic and endocrine dysfunction, but the specific contribution to human adipocyte dysfunction is unclear.
- What they did: SGBS adipocytes were treated with 1000 uM PA or BSA for 96 hours, assessing NFkB signalling, inflammation/metabolic-stress gene expression, lipid droplet and cell size, and insulin-induced Akt/AS160 phosphorylation; secretome effects were tested by ELISA/MILLIPLEX and by co-culture with immortalised human myotubes.
- The result: PA did not activate NFkB, increased MCP-1 and tended to raise IL-6 mRNA, enlarged lipid droplets and cells without insulin impairment, increased IL-6 and IL-8 secretion while tending to enhance adiponectin, and secretome did not blunt insulin-induced Akt phosphorylation in myotubes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.